Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2017
RSK2 drives cell motility by serine phosphorylation of LARG and activation of Rho GTPasesGeng-Xian Shi, Won Seok Yang, Ling Jin, et al.Translational Oncology|October 19, 2020
RasGRP1 induces autophagy and transformation-associated changes in primary human keratinocytesLauren L Fonseca, Won Seok Yang, Dirk Geerts, et al.Proceedings of the National Academy of Sciences of the United States of America|December 14, 2007
ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15Hema Vaidyanathan, John Opoku-Ansah, Sandra Pastorino, et al.Plos One|June 30, 2010
R-Ras regulates migration through an interaction with filamin A in melanoma cellsJoanna E Gawecka, Genevieve S Griffiths, Barbro Ek-Rylander, et al.European Journal of Inorganic Chemistry|July 12, 2021
Gold(I) Complexes with a Quinazoline Carboxamide Alkynyl Ligand: Synthesis, Cytotoxicity, and Mechanistic StudiesLeila Tabrizi, Won Seok Yang, Chetan Chintha, et al.Organometallics|December 2, 2014
Organometallic Titanocene-Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory PropertiesJacob Fernández-Gallardo, Benelita T Elie, Florian J Sulzmaier, et al.European Journal of Medicinal Chemistry|October 28, 2018
Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancerBenelita T Elie, Jacob Fernández-Gallardo, Natalia Curado, et al.Journal of Natural Products|January 14, 2015
Neopetrocyclamines A and B, polycyclic diamine alkaloids from the sponge Neopetrosia cf exiguaZhibin Liang, Florian J Sulzmaier, Wesley Y Yoshida, et al.Plos One|November 13, 2012
Englerin a selectively induces necrosis in human renal cancer cellsFlorian J Sulzmaier, Zhenwu Li, Mika L Nakashige, et al.ACS Pharmacology & Translational Science|August 25, 2020
Auranofin-Based Analogues Are Effective Against Clear Cell Renal Carcinoma <i>In Vivo</i> and Display No Significant Systemic ToxicityBenelita T Elie, Karen Hubbard, Buddhadev Layek, et al.Pageof 6